Timber Pharmaceuticals Stock Current Ratio
TMBRDelisted Stock | USD 1.72 0.01 0.58% |
Timber Pharmaceuticals fundamentals help investors to digest information that contributes to Timber Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Timber Stock. The fundamental analysis module provides a way to measure Timber Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Timber Pharmaceuticals stock.
Timber |
Timber Pharmaceuticals Company Current Ratio Analysis
Timber Pharmaceuticals' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Timber Pharmaceuticals Current Ratio | 2.45 X |
Most of Timber Pharmaceuticals' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Timber Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Timber Pharmaceuticals has a Current Ratio of 2.45 times. This is 15.81% lower than that of the Biotechnology sector and 65.0% lower than that of the Health Care industry. The current ratio for all United States stocks is 13.43% lower than that of the firm.
Timber Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Timber Pharmaceuticals' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Timber Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Timber Pharmaceuticals by comparing valuation metrics of similar companies.Timber Pharmaceuticals is currently under evaluation in current ratio category among its peers.
Timber Fundamentals
Return On Equity | -3.43 | |||
Return On Asset | -1.37 | |||
Current Valuation | (916.94 K) | |||
Shares Outstanding | 3.43 M | |||
Shares Owned By Insiders | 1.11 % | |||
Shares Owned By Institutions | 7.78 % | |||
Number Of Shares Shorted | 7.91 K | |||
Price To Book | 6.94 X | |||
Price To Sales | 17.19 X | |||
Revenue | 83.18 K | |||
Gross Profit | (5.26 M) | |||
EBITDA | (19.16 M) | |||
Net Income | (19.38 M) | |||
Cash And Equivalents | 11.22 M | |||
Cash Per Share | 3.78 X | |||
Total Debt | 331.15 K | |||
Debt To Equity | 0.06 % | |||
Current Ratio | 2.45 X | |||
Book Value Per Share | (0.86) X | |||
Cash Flow From Operations | (15.85 M) | |||
Short Ratio | 0.21 X | |||
Earnings Per Share | (1.97) X | |||
Target Price | 11.0 | |||
Beta | -0.65 | |||
Market Capitalization | 1.18 M | |||
Total Asset | 10.28 M | |||
Retained Earnings | (48.26 M) | |||
Working Capital | 4.77 M | |||
Z Score | -10.03 | |||
Net Asset | 10.28 M |
About Timber Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Timber Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Timber Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Timber Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Timber Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Timber Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Timber Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Timber Stock
0.85 | EC | Ecopetrol SA ADR Sell-off Trend | PairCorr |
0.84 | KO | Coca Cola Aggressive Push | PairCorr |
0.76 | TLK | Telkom Indonesia Tbk | PairCorr |
0.71 | BKRKY | Bank Rakyat | PairCorr |
0.7 | PPERY | Bank Mandiri Persero | PairCorr |
The ability to find closely correlated positions to Timber Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Timber Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Timber Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Timber Pharmaceuticals to buy it.
The correlation of Timber Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Timber Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Timber Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Timber Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Timber Stock
If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |